Skip to main content
American Journal of Human Genetics logoLink to American Journal of Human Genetics
. 1972 May;24(3):250–255.

Fabry's disease: absence of an -galactosidase isozyme.

S Wood, H L Nadler
PMCID: PMC1762282  PMID: 5028965

Full text

PDF
250

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brady R. O., Gal A. E., Bradley R. M., Martensson E., Warshaw A. L., Laster L. Enzymatic defect in Fabry's disease. Ceramidetrihexosidase deficiency. N Engl J Med. 1967 May 25;276(21):1163–1167. doi: 10.1056/NEJM196705252762101. [DOI] [PubMed] [Google Scholar]
  2. Brady R. O., Uhlendorf B. W., Jacobson C. B. Fabry's disease: antenatal detection. Science. 1971 Apr 9;172(3979):174–175. doi: 10.1126/science.172.3979.174. [DOI] [PubMed] [Google Scholar]
  3. Goldstone A., Konecny P., Koenig H. Lysosomal hydrolases: Conversion of acidic to basic forms by neuraminidase. FEBS Lett. 1971 Feb 12;13(1):68–72. doi: 10.1016/0014-5793(71)80667-1. [DOI] [PubMed] [Google Scholar]
  4. Hakomori S. I., Siddiqui B., Li Y. T., Li S. C., Hellerqvist C. G. Anomeric structure of globoside and ceramide grihexoside of human erythrocytes and hamster fibroblasts. J Biol Chem. 1971 Apr 10;246(7):2271–2277. [PubMed] [Google Scholar]
  5. Handa S., Ariga T., Miyatake T., Yamakawa T. Presence of alpha-anomeric glycosidic configuration in the glycolipids accumulated in kidney with Fabry's disease. J Biochem. 1971 Mar;69(3):625–627. [PubMed] [Google Scholar]
  6. Kint J. A. Fabry's disease: alpha-galactosidase deficiency. Science. 1970 Feb 27;167(3922):1268–1269. doi: 10.1126/science.167.3922.1268. [DOI] [PubMed] [Google Scholar]
  7. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  8. Mapes C. A., Anderson R. L., Sweeley C. C., Desnick R. J., Krivit W. Enzyme replacement in Fabry's disease, an inborn error of metabolism. Science. 1970 Sep 4;169(3949):987–989. doi: 10.1126/science.169.3949.987. [DOI] [PubMed] [Google Scholar]
  9. Matalon R., Dorfman A., Dawson G., Sweeley C. C. Glycolipid and mucopolysaccharide abnormality in fibroblasts of fabry's disease. Science. 1969 Jun 27;164(3887):1522–1523. doi: 10.1126/science.164.3887.1522. [DOI] [PubMed] [Google Scholar]
  10. Okada S., O'Brien J. S. Tay-Sachs disease: generalized absence of a beta-D-N-acetylhexosaminidase component. Science. 1969 Aug 15;165(3894):698–700. doi: 10.1126/science.165.3894.698. [DOI] [PubMed] [Google Scholar]
  11. Porter M. T., Fluharty A. L., Kihara H. Metachromatic leukodystrophy: arylsulfatase-A deficiency in skin fibroblast cultures. Proc Natl Acad Sci U S A. 1969 Mar;62(3):887–891. doi: 10.1073/pnas.62.3.887. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Romeo G., Migeon B. R. Genetic inactivation of the alpha-galactosidase locus in carriers of Fabry's disease. Science. 1970 Oct 9;170(3954):180–181. doi: 10.1126/science.170.3954.180. [DOI] [PubMed] [Google Scholar]
  13. SWEELEY C. C., KLIONSKY B. FABRY'S DISEASE: CLASSIFICATION AS A SPHINGOLIPIDOSIS AND PARTIAL CHARACTERIZATION OF A NOVEL GLYCOLIPID. J Biol Chem. 1963 Sep;238:3148–3150. [PubMed] [Google Scholar]

Articles from American Journal of Human Genetics are provided here courtesy of American Society of Human Genetics

RESOURCES